Floatz logo

Fludarabine

T-Cell Prolymphocytic Leukemia

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologySmall moleculePhase 3Dormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the T-Cell Prolymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2BB
Cytosin-Arabinosid
M.D. Anderson Cancer Center
Phase 2BB
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 2BB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 3BB
Evomela
Fred Hutchinson Cancer Center
Phase 2BB

View all 29 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →